Iarcstatisticalstudy

  Biosimilars are alternatives to existing biological medicines. Since biological medicines are expensive for certain sections of the population, the biosimilar vertical in the pharmaceuticals industry is gaining popularity. According to the Biosimilars Council, biosimilars are priced 10% to 35% lesser than branded biological medicines, and a sum of $250 billion could be saved through application of biosimilars in the next decade. Biosimilars will increase patient access to important life-saving medication by reducing overall costs in the pharmaceutical industry. The global  biosimilars market , which was valued at $5.5 billion in 2018, is estimated to grow at a CAGR of 38.21% during the forecast period of 2019 to 2025.   Request Sample Europe is currently the most lucrative region for the biosimilars market, and accounted for 74% of the global market share. However, the market is gaining traction in the North American region at a rapid pace. The U.S. Food and Drug Admini...

  Oncology Market Overview Oncology Market  size was valued at $136.7 billion in 2019 and is poised to grow at a CAGR of 11.9% during the forecast period 2020-2025. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Cancer is a disease, which involves the abnormal growth of cells that result in the formation of a tumor. However, benign tumor are not cancers. The abnormal tumor cells tend to spread to other local tissues and different parts of the body through the blood and lymphatic system. Treatment of cancer depends upon the stages of the disease progression. Increased prevalence of cancer, unhealthy lifestyle, and increasing geriatric population are the primary factors driving the growth of the oncology market. High market growth potential in developing nations, rise in the number of pipeline products, and the upsurge in demand for personalized medicines are poised to create new opportunities for the market players during th...